Was Turing Pharmaceuticals’ 5000% price increase a tipping point?
NIH SPRINT study sparks questions about overtreatment of mild hypertension
Dr. Richard Lehman: Why does having abnormal glucose tests cost the USA $245bn?
Bankrupted by cancer: Why “cost” is an important criterion in our review process
Why so little news about Medicare Advantage plan rate increases?
Stop blaming “demanding patients” for driving up health care costs
Why not discuss cost in news of new breast cancer drug approval?
Knee/hip surgery cost variability news would help more if it provided a link to the Blue Cross Blue Shield report
“Potential biomarker that could predict”? – caveats about psychiatric brain imaging & blogging about it
“Health care consumers in the dark” – no kidding